{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:49:32Z","timestamp":1790909372810,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012738","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T00:00:00Z","timestamp":1544227200000}}],"reference-count":196,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012738.pub2","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T08:51:35Z","timestamp":1544259095000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy"],"prefix":"10.1002","volume":"2018","author":[{"given":"Mohamad","family":"El Moheb","sequence":"first","affiliation":[{"name":"American University of Beirut Medical Center; Faculty of Medicine; Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johny","family":"Nicolas","sequence":"additional","affiliation":[{"name":"American University of Beirut Medical Center; Faculty of Medicine; Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assem M","family":"Khamis","sequence":"additional","affiliation":[{"name":"American University of Beirut Medical Center; Clinical Research Institute; Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghida","family":"Iskandarani","sequence":"additional","affiliation":[{"name":"American University of Beirut Medical Center; Faculty of Medicine; Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie A","family":"Akl","sequence":"additional","affiliation":[{"name":"American University of Beirut Medical Center; Department of Internal Medicine; Riad El Solh St Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Refaat","sequence":"additional","affiliation":[{"name":"American University of Beirut Medical Center; Department of Internal Medicine; Riad El Solh St Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,8]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD012738.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia: AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1023\/B:CEPR.0000023158.52511.76","article-title":"Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications","volume":"7","author":"Wijetunga","year":"2003","journal-title":"Cardiac Electrophysiology Review"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"Bansch","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1540-8159.1993.tb01628.x","article-title":"Cardiomyopathy Trial","volume":"16","author":"The Cardiomyopathy Trial Investigators","year":"1993","journal-title":"Pacing and Clinical Electrophysiology: PACE"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1540-8159.1992.tb05166.x","article-title":"Prospective studies assessing prophylactic therapy in high risk patients: the German Dilated Cardiomyopathy Study (GDCMS) - study design","volume":"15","author":"The German Dilated Cardiomyopathy Study Investigators","year":"1992","journal-title":"Pacing and Clinical Electrophysiology: PACE"},{"issue":"7","key":"10.1002\/14651858.CD012738.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.108.793273","article-title":"Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial","volume":"119","author":"Anand","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1054\/jcaf.2000.9501","article-title":"Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial","volume":"6","author":"Bristow","year":"2000","journal-title":"Journal of Cardiac Failure"},{"issue":"21","key":"10.1002\/14651858.CD012738.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012738.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jchf.2016.02.019","article-title":"Lessons learned and insights gained in the design, analysis, and outcomes of the COMPANION trial","volume":"4","author":"Bristow","year":"2016","journal-title":"JACC. Heart Failure"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2005.09.016","article-title":"Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial","volume":"46","author":"Carson","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"De Marco T Wolfel E Feldman AM Lowes B Higginbotham MB Ghali JK Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study Journal of Cardiac Failure 2008 9 18","DOI":"10.1016\/j.cardfail.2007.08.003"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.jacc.2005.08.033","article-title":"Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial","volume":"46","author":"Feldman","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.hrthm.2017.03.024","article-title":"Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial","volume":"14","author":"Kalscheur","year":"2017","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jce.13131","article-title":"Effect of PR interval on outcomes following cardiac resynchronization therapy: a secondary analysis of the COMPANION trial","volume":"28","author":"Lin","year":"2016","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/CIRCULATIONAHA.106.629261","article-title":"Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure","volume":"115","author":"Lindenfeld","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD012738.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.hrthm.2011.07.038","article-title":"Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION Trial","volume":"9","author":"Olshansky","year":"2012","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-5273(02)00585-5","article-title":"Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker-defibrillators reduce all-cause mortality and hospitalization","volume":"87","author":"Salukhe","year":"2003","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012738.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10840-007-9170-5","article-title":"The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective","volume":"21","author":"Sauer","year":"2008","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"25","key":"10.1002\/14651858.CD012738.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/CIRCULATIONAHA.106.642892","article-title":"Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial","volume":"114","author":"Saxon","year":"2006","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0020|cit20","unstructured":"Elming MB Nielsen JC Haarbo J Videbaek L Korup E Olesen LL Age and effect of implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure European Journal of Heart Failure 2016 344"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0021|cit21","doi-asserted-by":"crossref","unstructured":"Elming MB Nielsen JC Haarbo J Videbaek L Korup E Signorovitch J Age and outcomes of primary prevention implantable cardioverter defibrillators in patients with non-ischemic systolic heart failure Circulation 2017 1772 80","DOI":"10.1161\/CIRCULATIONAHA.117.028829"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/europace\/eux089","article-title":"Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease - indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey","volume":"19","author":"Haugaa","year":"2017","journal-title":"EP Europace"},{"issue":"13","key":"10.1002\/14651858.CD012738.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0024|cit24","unstructured":"NCT00542945 Danish ICD study in patients with dilated cardiomyopathy (DANISH) clinicaltrials.gov\/ct2\/show\/NCT00542945"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ahj.2016.06.016","article-title":"Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH)","volume":"179","author":"Thune","year":"2016","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Tronconi A Galizio N Gonzalez J Robles F Palazzo A Carnero G Which is the benefit of ICD in patients with ischemic cardiomyopathy compare with those with idiopathic dilated cardiomyopathy, from DANISH trial to real life EP Europace 2017 iii78","DOI":"10.1093\/ehjci\/eux141.119"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ahj.2008.02.026","article-title":"Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy","volume":"156","author":"Albert","year":"2008","journal-title":"American Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1540-8159.2009.02362.x","article-title":"Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy","volume":"32","author":"Daubert","year":"2009","journal-title":"Pacing and Clinical Electrophysiology: PACE"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCULATIONAHA.105.561571","article-title":"Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?","volume":"113","author":"Ellenbogen","year":"2006","journal-title":"Circulation"},{"issue":"21","key":"10.1002\/14651858.CD012738.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.jacc.2005.11.090","article-title":"Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators","volume":"47","author":"Kadish","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"20","key":"10.1002\/14651858.CD012738.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/archinte.167.20.2226","article-title":"Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study","volume":"167","author":"Passman","year":"2007","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.hrthm.2005.11.028","article-title":"Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial","volume":"3","author":"Rashba","year":"2006","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1023\/B:CEPR.0000023162.45506.c4","article-title":"DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE)","volume":"7","author":"Schaechter","year":"2003","journal-title":"Cardiac Electrophysiology Review"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.hrthm.2013.02.017","article-title":"Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE)","volume":"10","author":"Schliamser","year":"2013","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.hrthm.2013.02.017","article-title":"Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE)","volume":"10","author":"Schliamser","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0037|cit37","doi-asserted-by":"crossref","unstructured":"Adabag S Patton K Rector T Ensrud KE Vakil K Buxton AE Implantable cardioverter defibrillators continue to offer mortality benefit after improvement in ejection fraction to above 35%: results from the sudden cardiac death in heart failure trial Circulation 2016 3","DOI":"10.1161\/circ.134.suppl_1.13142"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Adabag S Patton KK Buxton AE Rector TS Ensrud KE Vakil K Association of implantable cardioverter defibrillators with survival in patients with and without improved ejection fraction: secondary analysis of the sudden cardiac death in heart failure trial JAMA Cardiology 2017 767 74","DOI":"10.1001\/jamacardio.2017.1413"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0041|cit39","first-page":"323","article-title":"Sudden Cardiac Death-Heart Failure Trial (SCD-HeFT)","volume-title":"Arrhythmia Treatment and Therapy: Evaluation of Clinical Trial Evidence","author":"Bardy","year":"2000"},{"issue":"9","key":"10.1002\/14651858.CD012738.pub2-BIB0039|cit40","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.hrthm.2012.06.018","article-title":"Long-term follow-up in the sudden cardiac death heart failure trial (SCD-HEFT)","volume":"9","author":"Bardy","year":"2012","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0040|cit41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"23","key":"10.1002\/14651858.CD012738.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.jacc.2014.02.602","article-title":"Use of the 6-min walk distance to identify\u00a0variations in treatment benefits from\u00a0implantable cardioverter-defibrillator and\u00a0amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in\u00a0Heart\u00a0Failure Trial)","volume":"63","author":"Fishbein","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"20","key":"10.1002\/14651858.CD012738.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/CIRCULATIONAHA.106.661397","article-title":"Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"115","author":"Freudenberger","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ahj.2008.08.007","article-title":"Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"156","author":"Gula","year":"2008","journal-title":"American Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD012738.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa0706719","article-title":"Quality of life with defibrillator therapy or amiodarone in heart failure","volume":"359","author":"Mark","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.105.581884","article-title":"Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"114","author":"Mark","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ahj.2007.10.022","article-title":"Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"155","author":"Mitchell","year":"2008","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0048|cit48","unstructured":"NCT00000609 Sudden cardiac death in heart failure trial (SCD-HeFT) clinicaltrials.gov\/ct2\/show\/NCT00000609"},{"issue":"13","key":"10.1002\/14651858.CD012738.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jacc.2007.11.065","article-title":"Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study","volume":"51","author":"Olshansky","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"issue":"22","key":"10.1002\/14651858.CD012738.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","article-title":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure","volume":"120","author":"Packer","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.hrthm.2010.11.033","article-title":"Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"8","author":"Piccini","year":"2011","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1002\/14651858.CD012738.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1540-8167.2008.01129.x","article-title":"Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial","volume":"19","author":"Russo","year":"2008","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"5","key":"10.1002\/14651858.CD012738.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.amjcard.2011.10.033","article-title":"How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with \"SCD-HeFT criteria?\"","volume":"109","author":"Zecchin","year":"2012","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00392-007-0586-9","article-title":"Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter defibrillator (CRT-D) for the treatment of chronic heart failure from a German health care system perspective","volume":"97","author":"Aidelsburger","year":"2008","journal-title":"Clinical Research in Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012738.pub2-BIB0055|cit55","first-page":"65","article-title":"Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death","volume":"20","author":"Amara","year":"2018","journal-title":"Europace"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0735-1097(99)00234-X","article-title":"Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial","volume":"34","author":"Exner","year":"1999","journal-title":"Journal of the American College of Cardiology"},{"issue":"17","key":"10.1002\/14651858.CD012738.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/01.CIR.0000015504.57641.D0","article-title":"Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy","volume":"105","author":"Larsen","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Schron EB Exner DV Yao Q Jenkins LS Steinberg JS Cook JR Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks Circulation 2002 589 94","DOI":"10.1161\/hc0502.103330"},{"issue":"22","key":"10.1002\/14651858.CD012738.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","author":"The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/europace\/eux203","article-title":"Do women benefit equally as men from the primary prevention implantable cardioverter-defibrillator?","volume":"20","author":"Barra","year":"2018","journal-title":"Europace"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Biton Y Rosero S Moss A Zareba W Kutyifa V Baman J Long-term survival with implantable cardioverter-defibrillator in different symptomatic functional classes of heart failure American Journal of Cardiology 2018 615 20","DOI":"10.1016\/j.amjcard.2017.11.032"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0062|cit62","doi-asserted-by":"crossref","unstructured":"Adamson PB Chung ES Sutton MGS Sidhu MK Mealing S Padhiar A Cost-effectiveness of bi-ventricular pacemakers vs. RV pacemakers and bi-ventricular defibrillators vs. dual chamber defibrillators in patients with atrioventricular block and systolic dysfunction: all-patient and subgroup analyses from the BLOCK-HF clinical trial Circulation 2014 4","DOI":"10.1161\/circ.130.suppl_2.16317"},{"issue":"17","key":"10.1002\/14651858.CD012738.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMoa1210356","article-title":"Biventricular pacing for atrioventricular block and systolic dysfunction","volume":"368","author":"Curtis","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijcard.2008.05.073","article-title":"Is combined resynchronisation and implantable defibrillator therapy a cost-effective option for left ventricular dysfunction?","volume":"137","author":"Bond","year":"2009","journal-title":"International Journal of Cardiology"},{"issue":"24","key":"10.1002\/14651858.CD012738.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1136\/heartjnl-2012-301845","article-title":"Cost-effectiveness of cardiac resynchronisation therapy","volume":"98","author":"Boriani","year":"2012","journal-title":"Heart"},{"issue":"1","key":"10.1002\/14651858.CD012738.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0266462307051586","article-title":"Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic evaluation","volume":"23","author":"Bryant","year":"2007","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"11","key":"10.1002\/14651858.CD012738.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0300-8932(10)70291-8","article-title":"Cardiac resynchronisation therapy is cost effective","volume":"63","author":"Calvert","year":"2010","journal-title":"Revista Espanola De Cardiologia"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0068|cit68","doi-asserted-by":"crossref","unstructured":"Connolly SJ Gent M Roberts RS Dorian P Roy D Sheldon RS Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 2000 1297 302","DOI":"10.1161\/01.CIR.101.11.1297"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0069|cit69","doi-asserted-by":"crossref","unstructured":"Cowie MR Marshall D Drummond M Ferko N Maschio M Ekman M Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population Europace 2009 716 26","DOI":"10.1093\/europace\/eup068"},{"issue":"17","key":"10.1002\/14651858.CD012738.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.CIR.0000066319.56234.C8","article-title":"Defibrillator versus beta-blockers for unexplained death in Thailand (DEBUT): a randomized clinical trial","volume":"107","author":"Nademanee","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2018.03.087","article-title":"Cardiac resynchronization therapy in the ageing population - with or without an implantable defibrillator?","volume":"263","author":"Doring","year":"2018","journal-title":"International Journal of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2459\/JCM.0000000000000584","article-title":"Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillator","volume":"18","author":"Drozd","year":"2017","journal-title":"Journal of Cardiovascular Medicine"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1540-8167.2012.02435.x","article-title":"Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy","volume":"23 Suppl 1","author":"Hua","year":"2012","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2009.10.011","article-title":"Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF","volume":"158","author":"Curtis","year":"2009","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0075|cit75","unstructured":"NCT00303979 IMPROVE HF: registry to improve the use of evidence-based heart failure therapies in the outpatient setting (IMPROVE-HF) clinicaltrials.gov\/ct2\/show\/NCT00303979"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/ejhf.185","article-title":"Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience","volume":"16","author":"Kutyifa","year":"2014","journal-title":"European Journal of Heart Failure"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.amjcard.2018.02.040","article-title":"Comparison of long-term survival benefits with cardiac resynchronization therapy in patients with mild heart failure with versus without diabetes mellitus (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT))","volume":"121","author":"Kutyifa","year":"2018","journal-title":"American Journal of Cardiology"},{"issue":"26","key":"10.1002\/14651858.CD012738.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia","volume":"335","author":"Moss","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD012738.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/01.CIR.97.21.2129","article-title":"The cost-effectiveness of automatic implantable cardiac defibrillators","volume":"97","author":"Mushlin","year":"1998","journal-title":"Circulation"},{"issue":"5B","key":"10.1002\/14651858.CD012738.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"33F","DOI":"10.1016\/S0002-9149(97)00476-1","article-title":"Approach to cost-effectiveness assessment in the MADIT trial. Multicenter Automatic Defibrillator Implantation Trial","volume":"80","author":"Mushlin","year":"1997","journal-title":"American Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD012738.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.amjcard.2017.01.035","article-title":"Comparison of multivariate risk estimation models to predict prognosis in patients with implantable cardioverter defibrillators with or without cardiac resynchronization therapy","volume":"119","author":"Akoudad","year":"2017","journal-title":"American Journal of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1002\/14651858.CD012738.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1161\/01.CIR.0000086777.82110.F5","article-title":"MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy","volume":"108","author":"Reynolds","year":"2003","journal-title":"Circulation"},{"issue":"21","key":"10.1002\/14651858.CD012738.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1136\/heartjnl-2015-308883","article-title":"Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure","volume":"102","author":"Mealing","year":"2016","journal-title":"Heart"},{"issue":"Abstract_Supple","key":"10.1002\/14651858.CD012738.pub2-BIB0085|cit85","first-page":"3","article-title":"Cardiac resynchronization therapy reduces the risk of hospitalization for heart failure and length of stay: results from the MIRACLE trial","volume":"23","author":"Abraham","year":"2002","journal-title":"European Heart Journal"},{"issue":"24","key":"10.1002\/14651858.CD012738.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0087|cit87","unstructured":"Abraham WT Fisher WG Smith AL Delurgio DB Loh E Kocovic DZ Multicenter InSync randomized clinical evaluation (MIRACLE): Results of a randomized, double-blind, controlled trial to assess cardiac resynchronization therapy in heart failure patients Circulation 2001 618"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1388-9842(02)00018-1","article-title":"Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study","volume":"4","author":"Gras","year":"2002","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0195-668X(03)94998-0","article-title":"Clinical efficacy of one year cardiac resynchronization therapy in heart failure patients stratified by QRS duration: results of the PATH-CHF II trial","volume":"24","author":"Butter","year":"2003","journal-title":"European Heart Journal"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1540-8167.2006.00658.x","article-title":"Resynchronization\/defibrillation for advanced heart failure trial (RAFT)","volume":"17","author":"Cao","year":"2006","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"25","key":"10.1002\/14651858.CD012738.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 21","key":"10.1002\/14651858.CD012738.pub2-BIB0092|cit92","first-page":"A13471","article-title":"Abstract 13471: implantable defibrillators improve survival in mildly symptomatic heart failure patients receiving cardiac resynchronization therapy: analysis of the 5-year follow-up of REVERSE","volume":"126","author":"Gold","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jchf.2016.10.014","article-title":"Economic value and cost-effectiveness of cardiac resynchronization therapy among patients with mild heart failure: projections from the REVERSE long-term follow-up","volume":"5","author":"Gold","year":"2017","journal-title":"JACC. Heart Failure"},{"issue":"23","key":"10.1002\/14651858.CD012738.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0095|cit95","unstructured":"NCT00271154 Resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) clinicaltrials.gov\/ct2\/show\/NCT00271154"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1524-4733.2009.00608.x","article-title":"Cost-effectiveness of implantable cardioverter-defibrillators in Brazil: primary prevention analysis in the public sector","volume":"13","author":"Ribeiro","year":"2010","journal-title":"Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0097|cit97","doi-asserted-by":"crossref","unstructured":"Richardson TD Hale L Arteaga C Xu M Keebler M Schlendorf K Prospective randomized evaluation of implantable cardioverter-defibrillator programming in patients with a left ventricular assist device Journal of the American Heart Association 2018 e007748","DOI":"10.1161\/JAHA.117.007748"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0098|cit98","first-page":"16","article-title":"Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients","volume":"16","author":"Wang","year":"2018","journal-title":"Indian Pacing and Electrophysiology Journal"},{"issue":"1","key":"10.1002\/14651858.CD012738.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/eurheartj\/ehl382","article-title":"The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator","volume":"28","author":"Yao","year":"2006","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"e12253","DOI":"10.1111\/1755-5922.12253","article-title":"Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"35","author":"Akel","year":"2017","journal-title":"Cardiovascular Therapeutics"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD012738.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0735-1097(17)33774-9","article-title":"Role of implantable defibrillators in primary prevention of mortality in non-ischemic cardiomyopathy patients","volume":"69","author":"Akinapelli","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"e57132","DOI":"10.1371\/journal.pone.0057132","article-title":"Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers","volume":"8","author":"Akl","year":"2013","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2017.0630","article-title":"Primary prevention implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy: a meta-analysis","volume":"2","author":"Al-Khatib","year":"2017","journal-title":"JAMA Cardiology"},{"issue":"14","key":"10.1002\/14651858.CD012738.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0105|cit105","first-page":"230","article-title":"Implantable cardiac defibrillator and mortality in non-ischaemic cardiomyopathy: an updated meta-analysis","volume":"104","author":"Alba","year":"2018","journal-title":"Heart (British Cardiac Society)"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of\u00a0hospitalizations for heart failure: lessons\u00a0learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"22","key":"10.1002\/14651858.CD012738.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","author":"Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"e016352","DOI":"10.1136\/bmjopen-2017-016352","article-title":"Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials","volume":"7","author":"Barakat","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0111|cit111","first-page":"144","article-title":"Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis","volume":"104","author":"Beggs","year":"2018","journal-title":"Heart (British Cardiac Society)"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0113|cit113","unstructured":"Centre for Reviews and Dissemination Search strategies www.crd.york.ac.uk\/crdweb\/searchstrategies.asp#nhseedmedline"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0114|cit114","first-page":"f55","article-title":"Benefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta-analysis","volume":"346","author":"Chatterjee","year":"2013","journal-title":"BMJ (Clinical research ed.)"},{"issue":"15","key":"10.1002\/14651858.CD012738.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012738.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0117|cit117","first-page":"1088","article-title":"No evidence of myocardial oxygen deprivation in nonischemic heart failure","volume":"8","author":"Dass","year":"2015","journal-title":"Circulation: Heart Failure"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nurpra.2007.01.015","article-title":"Cardiomyopathy: an overview","volume":"3","author":"Daughenbaugh","year":"2007","journal-title":"Journal for Nurse Practitioners"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1076-7460.2004.03476.x","article-title":"Mode of death from congestive heart failure: implications for clinical management","volume":"13","author":"Derfler","year":"2004","journal-title":"American Journal of Geriatric Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0147-9563(05)80071-8","article-title":"Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillator","volume":"24","author":"Dougherty","year":"1995","journal-title":"Heart & Lung: the Journal of Critical Care"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0121|cit121","first-page":"494","article-title":"Internal cardioverter defibrillator device discharge: experiences of patients and family members","volume":"22","author":"Dunbar","year":"1993","journal-title":"Heart & Lung: the Journal of Critical Care"},{"issue":"9","key":"10.1002\/14651858.CD012738.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jclinepi.2013.03.014","article-title":"Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers","volume":"66","author":"Ebrahim","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD012738.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jclinepi.2013.11.014","article-title":"Addressing continuous data measured with different instruments for participants excluded from trial analysis: a guide for systematic reviewers","volume":"67","author":"Ebrahim","year":"2014","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD012738.pub2-BIB0124|cit124","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012738","article-title":"Implantable cardiac defibrillators for patients with non-ischaemic cardiomyopathy","author":"Moheb","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"19","key":"10.1002\/14651858.CD012738.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/CIRCULATIONAHA.117.028829","article-title":"Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure","volume":"136","author":"Elming","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0735-1097(95)00482-3","article-title":"Classification of death in antiarrhythmia trials","volume":"27","author":"Epstein","year":"1996","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012738.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"e000198","DOI":"10.1136\/openhrt-2014-000198","article-title":"A systematic review of ICD complications in randomised controlled trials versus registries: is our \u2018real-world\u2019 data an underestimation?","volume":"2","author":"Ezzat","year":"2005","journal-title":"Open Heart"},{"issue":"5","key":"10.1002\/14651858.CD012738.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/0272989X10375853","article-title":"Presenting the results of Cochrane systematic reviews to a consumer audience: a qualitative study","volume":"30","author":"Glenton","year":"2010","journal-title":"Medical Decision Making"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.116.026056","article-title":"Implantable cardioverter-defibrillator for non ischemic cardiomyopathy: an updated meta-analysis","volume":"135","author":"Golwala","year":"2016","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0130|cit130","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"5","key":"10.1002\/14651858.CD012738.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02602348","article-title":"Development and testing of a new measure of health status for clinical trials in heart failure","volume":"4","author":"Guyatt","year":"1989","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4065\/77.4.371","article-title":"Methods to explain the clinical significance of health status measures","volume":"77","author":"Guyatt","year":"2002","journal-title":"Mayo Clinic Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles - continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0143|cit143","unstructured":"Guyatt GH Ebrahim S Alonso-Coello P Johnston BC Mathioudakis AG Briel M GRADE guidelines 17: Assessing the risk of bias associated with missing participant outcome data in a body of evidence Journal of Clinical Epidemiology 10.1016\/j.jclinepi.2017.05.005"},{"issue":"1","key":"10.1002\/14651858.CD012738.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0033-3182(99)71277-6","article-title":"PTSD and automatic implantable cardioverter defibrillators","volume":"40","author":"Hamner","year":"1999","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCHEARTFAILURE.107.743146","article-title":"Death in heart failure: a community perspective","volume":"1","author":"Henkel","year":"2008","journal-title":"Circulation. Heart Failure"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0146|cit146","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003040.pub2","article-title":"Angiotensin receptor blockers for heart failure","author":"Heran","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012738.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(03)01042-8","article-title":"Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias","volume":"42","author":"Higgins","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0148|cit148","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0149|cit149","unstructured":"Higgins J Altman G Sterne J Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4 Suppl A","key":"10.1002\/14651858.CD012738.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The epidemiology of heart failure: the Framingham Study","volume":"22","author":"Ho","year":"1993","journal-title":"Journal of the American College of Cardiology"},{"issue":"22","key":"10.1002\/14651858.CD012738.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1161\/01.CIR.0000129322.97266.F3","article-title":"Implantable defibrillators and sudden cardiac death","volume":"109","author":"Josephson","year":"2004","journal-title":"Circulation"},{"issue":"18","key":"10.1002\/14651858.CD012738.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/M17-0120","article-title":"Implantable cardioverter-defibrillators for primary prevention in patients with ischemic or nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"167","author":"Kolodziejczak","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012738.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD012738.pub2-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1001\/archpsyc.65.11.1324","article-title":"Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study","volume":"65","author":"Ladwig","year":"2008","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0156|cit156","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD012738.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/jce.13192","article-title":"Mortality effect of ICD in primary prevention of nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"28","author":"Luni","year":"2017","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"41","key":"10.1002\/14651858.CD012738.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1093\/eurheartj\/ehv455","article-title":"Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study","volume":"36","author":"Marijon","year":"2015","journal-title":"European Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD012738.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa0706719","article-title":"Quality of life with defibrillator therapy or amiodarone in heart failure","volume":"359","author":"Mark","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012738.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.21037\/cdt.2017.06.06","article-title":"Implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"7","author":"Masri","year":"2017","journal-title":"Cardiovascular Diagnosis and Therapy"},{"issue":"8","key":"10.1002\/14651858.CD012738.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012","volume":"14","author":"McMurray","year":"2012","journal-title":"European Journal of Heart Failure"},{"issue":"1","key":"10.1002\/14651858.CD012738.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI62862","article-title":"Genetic mutations and mechanisms in dilated cardiomyopathy","volume":"123","author":"McNally","year":"2013","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJM198008073030607","article-title":"Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings","volume":"303","author":"Mirowski","year":"1980","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1002\/14651858.CD012738.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1053\/euhj.2000.2533","article-title":"The prognosis of heart failure in the general population. The Rotterdam Study","volume":"22","author":"Mosterd","year":"2001","journal-title":"European Heart Journal"},{"issue":"9","key":"10.1002\/14651858.CD012738.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacep.2017.02.006","article-title":"Efficacy of implantable cardioverter-defibrillator therapy in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials","volume":"3","author":"Narayanan","year":"2017","journal-title":"JACC. Clinical Electrophysiology"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/heart.83.6.634","article-title":"The left ventricular dysfunction questionnaire (LVD-36): reliability, validity, and responsiveness","volume":"83","author":"O'Leary","year":"2000","journal-title":"Heart"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD012738.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0735-1097(17)34293-6","article-title":"Implantable cardioverter defibrillators for the prevention of mortality in patients with non-ischemic cardiomyopathy: a meta-analysis of randomized control trials","volume":"69","author":"Omar","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"22","key":"10.1002\/14651858.CD012738.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","article-title":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial","volume":"120","author":"Packer","year":"2009","journal-title":"Circulation"},{"issue":"24","key":"10.1002\/14651858.CD012738.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.rec.2016.11.005","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"69","author":"Ponikowski","year":"2016","journal-title":"Revista Espanola de Cardiologia (English ed.)"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0300-8932(10)70089-0","article-title":"Mortality and cause of death in patients with heart failure: findings at a specialist multidisciplinary heart failure unit","volume":"63","author":"Pons","year":"2010","journal-title":"Revista Espanol de Cardiologia"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCULATIONAHA.112.000762","article-title":"Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy","volume":"129","author":"Poole","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD012738.pub2-BIB0174|cit174","first-page":"198","article-title":"Patients' self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire","volume":"3","author":"Rector","year":"1987","journal-title":"Heart Failure"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0175|cit175","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10840-017-0260-8","article-title":"Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials","volume":"49","author":"Romero","year":"2017","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"7","key":"10.1002\/14651858.CD012738.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.CIR.98.7.663","article-title":"Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study","volume":"98","author":"Rosenqvist","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD012738.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"5","key":"10.1002\/14651858.CD012738.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/hc0502.103330","article-title":"Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks","volume":"105","author":"Schron","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0180|cit180","unstructured":"Sch\u00fcnemann H Oxman A Vist G Higgins J Deeks J Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD012738.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/heart.87.5.488","article-title":"Quality of life and psychological functioning of ICD patients","volume":"87","author":"Sears","year":"2002","journal-title":"Heart"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD012738.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0735-1097(17)33710-5","article-title":"Prophylactic defibrillator implantation in patients with non-ischemic cardiomyopathy: an updated comprehensive meta-analysis of randomized controlled trials","volume":"69","author":"Shah","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/hrt.2008.145243","article-title":"Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry","volume":"95","author":"Shiga","year":"2009","journal-title":"Heart (British Cardiac Society)"},{"issue":"22","key":"10.1002\/14651858.CD012738.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/eurheartj\/ehx028","article-title":"Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials","volume":"38","author":"Shun-Shin","year":"2017","journal-title":"European Heart Journal"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD012738.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0735-1097(17)33801-9","article-title":"Reduced mortality benefit with prophylactic implantable cardioverter defibrillator in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"69","author":"Singh","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012738.pub2-BIB0186|cit186","unstructured":"StataCorp LP Stata Statistical Software: Release 13 2013"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/jce.13204","article-title":"Implantable cardioverter defibrillators for primary prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"28","author":"Stavrakis","year":"2017","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD012738.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0735-1097(17)33749-X","article-title":"Implantable cardioverter defibrillator for the prevention of mortality in non-ischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"69","author":"Turagam","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD012738.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1467-9450.1987.tb00758.x","article-title":"Self-assessment of quality of life in severe heart failure. An instrument for clinical use","volume":"28","author":"Wiklund","year":"1987","journal-title":"Scandinavian Journal of Psychology"},{"issue":"7","key":"10.1002\/14651858.CD012738.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00392-017-1079-0","article-title":"Implantable cardioverter\/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials","volume":"106","author":"Wolff","year":"2017","journal-title":"Clinical Research in Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD012738.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1373\/clinchem.2007.095679","article-title":"National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure","volume":"53","author":"Wu","year":"2007","journal-title":"Clinical Chemistry"},{"issue":"5","key":"10.1002\/14651858.CD012738.pub2-BIB0192|cit192","first-page":"417","article-title":"Effectiveness of implantation of cardioverter-defibrillators therapy in patients with non-ischemic heart failure: an updated systematic review and meta-analysis","volume":"32","author":"Xing","year":"2017","journal-title":"Brazilian Journal of Cardiovascular Surgery"},{"issue":"16","key":"10.1002\/14651858.CD012738.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"14","key":"10.1002\/14651858.CD012738.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/eurheartj\/ehi268","article-title":"Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials","volume":"26","author":"Yap","year":"2005","journal-title":"European Heart Journal"},{"issue":"20","key":"10.1002\/14651858.CD012738.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.289.20.2685","article-title":"Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial","volume":"289","author":"Young","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD012738.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nature Reviews. Cardiology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012738.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T04:35:41Z","timestamp":1720845341000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012738.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,8]]},"references-count":196,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012738.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,8]]}}}